Xilingyuan Pharmaceutical is a generic drug and innovative drug developer.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 25, 2022 | Series B | ¥90M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Chengdu Hi-tech Investment Group | — | Series B |
Chengdu Biocity | — | Series B |